Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...
The CDC never recommended babies get 72 injections . In 2024 and part of 2025, before the Trump administration’s changes, it recommended children up to age 2 get up to 12 different vaccines protecting ...
It depends. There have been a few clinical trials on the impact of GLP-1 injectable medications on weight loss with different ...
Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...
SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting
HIGHLIGHTSFollowing an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review ...
Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious ...
Since we know that eating less food often means getting fewer nutrients, a high-quality multivitamin acts as an insurance ...
A single dose of either bivalent or nonvalent HPV vaccine was just as protective as the standard two doses of either vaccine ...
The United States Patent and Trademark Office has issued U.S. Patent No. 12,514,854 B2, an Orange Book-listable patent ...
Supplements that can help you stay physically and mentally healthy during the winter include vitamin D, zinc, vitamin C, and ...
The optimal hydroxychloroquine blood level in lupus is between 750 ng/mL and 1,150 ng/mL, which can help prevent active ...
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and previously-treated nusinersen patients with SMA1Biogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback